Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
P2-VP8 Subunit Rotavirus Vaccine in Healthy Toddlers and Infants
NCT02109484Phase 2Completed
- Sponsor
- PATH
- Start
- Mar 2014
- Primary completion
- Nov 2015
- Modality
- Split/Subunit Vaccines, Recombinant Protein Vaccines, Peptide-based Cancer Vaccines
- Countries
- 1
01
Overview
A Phase 2 trial of trivalent P2-VP8 subunit rotavirus vaccine in rotavirus infection, sponsored by PATH. Started Mar 2014; status: completed.
02
Drugs
trivalent P2-VP8 subunit rotavirus vaccine
03
Conditions
rotavirus infection
Beyond the preview
Go deeper on NCT02109484.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02109484.